Bioscience

New cancer treatment gives hope to lymphoma and leukemia patients

February 26, 2010

By Flinn Foundation

[Source: TGen] – Cancer researchers have high hopes for a new therapy for patients with certain types of lymphoma and leukemia.

PCI-32765 is a new drug being assessed in a Phase I clinical trial at the Virginia G. Piper Cancer Center in collaboration with the Clinical Division of the Translational Genomics Research Institute.

This is one of 35 such trials under way through a partnership between the Virginia G. Piper Cancer Center at Scottsdale Healthcare and TGen, which enables molecular and genomic discoveries to reach patients through Phase I trials as quickly as possible.

For more information: New cancer treatment gives hope to lymphoma and leukemia patients